Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Invested Capital (2016 - 2025)

STRATA Skin Sciences' Invested Capital history spans 14 years, with the latest figure at $3.2 million for Q3 2025.

  • For Q3 2025, Invested Capital fell 66.08% year-over-year to $3.2 million; the TTM value through Sep 2025 reached $3.2 million, down 66.08%, while the annual FY2024 figure was $5.0 million, 60.81% down from the prior year.
  • Invested Capital for Q3 2025 was $3.2 million at STRATA Skin Sciences, up from $532000.0 in the prior quarter.
  • Across five years, Invested Capital topped out at $26.2 million in Q3 2021 and bottomed at $532000.0 in Q2 2025.
  • The 5-year median for Invested Capital is $16.9 million (2023), against an average of $15.7 million.
  • The largest annual shift saw Invested Capital fell 3.24% in 2021 before it plummeted 94.4% in 2025.
  • A 5-year view of Invested Capital shows it stood at $25.4 million in 2021, then decreased by 14.1% to $21.8 million in 2022, then plummeted by 41.88% to $12.7 million in 2023, then plummeted by 60.81% to $5.0 million in 2024, then tumbled by 35.86% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Invested Capital are $3.2 million (Q3 2025), $532000.0 (Q2 2025), and $3.0 million (Q1 2025).